These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

520 related items for PubMed ID: 22360819

  • 1. CHADS2 and CHA2DS2-VASc risk factors to predict first cardiovascular hospitalization among atrial fibrillation/atrial flutter patients.
    Naccarelli GV, Panaccio MP, Cummins G, Tu N.
    Am J Cardiol; 2012 May 15; 109(10):1526-33. PubMed ID: 22360819
    [Abstract] [Full Text] [Related]

  • 2. Reliable identification of "truly low" thromboembolic risk in patients initially diagnosed with "lone" atrial fibrillation: the Belgrade atrial fibrillation study.
    Potpara TS, Polovina MM, Licina MM, Marinkovic JM, Prostran MS, Lip GY.
    Circ Arrhythm Electrophysiol; 2012 Apr 15; 5(2):319-26. PubMed ID: 22319004
    [Abstract] [Full Text] [Related]

  • 3. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V, Marín F, Manzano-Fernández S, Gallego P, Vílchez JA, Valdés M, Vicente V, Lip GY.
    J Am Coll Cardiol; 2013 Dec 10; 62(23):2199-204. PubMed ID: 24055744
    [Abstract] [Full Text] [Related]

  • 4. Incremental cost burden to US healthcare payers of atrial fibrillation/atrial flutter patients with additional risk factors.
    Amin AN, Jhaveri M, Lin J.
    Adv Ther; 2011 Oct 10; 28(10):907-26. PubMed ID: 21971681
    [Abstract] [Full Text] [Related]

  • 5. Usefulness of transesophageal echocardiography to confirm clinical utility of CHA2DS2-VASc and CHADS2 scores in atrial flutter.
    Parikh MG, Aziz Z, Krishnan K, Madias C, Trohman RG.
    Am J Cardiol; 2012 Feb 15; 109(4):550-5. PubMed ID: 22133753
    [Abstract] [Full Text] [Related]

  • 6. CHADS(2) and CHA(2)DS(2)-VASc scores in the prediction of clinical outcomes in patients with atrial fibrillation after catheter ablation.
    Chao TF, Lin YJ, Tsao HM, Tsai CF, Lin WS, Chang SL, Lo LW, Hu YF, Tuan TC, Suenari K, Li CH, Hartono B, Chang HY, Ambrose K, Wu TJ, Chen SA.
    J Am Coll Cardiol; 2011 Nov 29; 58(23):2380-5. PubMed ID: 22115643
    [Abstract] [Full Text] [Related]

  • 7. Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.
    Taillandier S, Olesen JB, Clémenty N, Lagrenade I, Babuty D, Lip GY, Fauchier L.
    J Cardiovasc Electrophysiol; 2012 Jul 29; 23(7):708-13. PubMed ID: 22268375
    [Abstract] [Full Text] [Related]

  • 8. Temporal pattern and costs of rehospitalization in atrial fibrillation/atrial flutter patients with one or more additional risk factors.
    Amin AN, Jhaveri M, Lin J.
    J Med Econ; 2012 Jul 29; 15(3):548-55. PubMed ID: 22352988
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Risk stratification schemes, anticoagulation use and outcomes: the risk--treatment paradox in patients with newly diagnosed non-valvular atrial fibrillation.
    Sandhu RK, Bakal JA, Ezekowitz JA, McAlister FA.
    Heart; 2011 Dec 29; 97(24):2046-50. PubMed ID: 22076011
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.
    Melgaard L, Gorst-Rasmussen A, Lane DA, Rasmussen LH, Larsen TB, Lip GY.
    JAMA; 2015 Sep 08; 314(10):1030-8. PubMed ID: 26318604
    [Abstract] [Full Text] [Related]

  • 16. Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.
    Kornej J, Hindricks G, Kosiuk J, Arya A, Sommer P, Husser D, Rolf S, Richter S, Piorkowski C, Gaspar T, Lip GY, Bollmann A.
    Circ Arrhythm Electrophysiol; 2013 Oct 08; 6(5):868-74. PubMed ID: 24047706
    [Abstract] [Full Text] [Related]

  • 17. Renal impairment and ischemic stroke risk assessment in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project.
    Banerjee A, Fauchier L, Vourc'h P, Andres CR, Taillandier S, Halimi JM, Lip GY.
    J Am Coll Cardiol; 2013 May 21; 61(20):2079-87. PubMed ID: 23524209
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study.
    Friberg L, Rosenqvist M, Lip GY.
    Eur Heart J; 2012 Jun 21; 33(12):1500-10. PubMed ID: 22246443
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Improving stroke risk stratification in atrial fibrillation.
    Lip GY, Halperin JL.
    Am J Med; 2010 Jun 21; 123(6):484-8. PubMed ID: 20569748
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.